Dr. Isabel Sharkar, NMD, is co-founder of Indigo Integrative Health Clinic in Washington, D.C., a thriving clinic that has been serving the local community in health restoration and body optimization for over a decade. Being in constant pursuit for truth and healing Dr. Isabel graduated in 2011 from Southwest College of Naturopathic Medicine as a Doctor of Naturopathic Medicine.
GLP-1 receptor agonists — drugs like Ozempic, Wegovy, and Mounjaro — have transformed how we treat obesity and metabolic disease. But are they right for you? Here's what the science actually says.
Key Takeaways
GLP-1 agonists mimic a natural hormone that regulates blood sugar and appetite.
Originally developed for type 2 diabetes, drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)were later found to produce significant weight loss — even in patients without diabetes.
That discovery led to FDA approval for obesity treatment and a cultural moment that has made these medications impossible to ignore.
These drugs act on multiple systems in the body simultaneously:
The result is a coordinated reduction in hunger and blood sugar — which is why the weight loss results have been so striking.
Both are effective. But they work differently.
Semaglutide targets the GLP-1 receptor only. It produces meaningful weight loss and improved blood sugar control, and it has the most long-term safety data.
Tirzepatide targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide)receptors. Clinical trials show greater average weight loss compared tosemaglutide. Patients who plateau on semaglutide sometimes switch totirzepatide for additional benefit.
Retatrutide — the next generation — targets three receptors (GLP-1, GIP, and glucagon) and has shown up to 25% weight loss in early studies.
Oral forms are now available, with more in the pipeline.
Real-world head-to-head trials betweensemaglutide and tirzepatide are still limited. The best choice depends on your health history, goals, and how your body responds — something your Indigo Health Clinic provider can help you determine.
No medication is without risk. The most common side effects are gastrointestinal and typically improve with time.
Common:
Serious but rare:
Less discussed but important:
At Indigo Health Clinic, we require thyroid and gallbladder ultrasounds before starting any GLP-1 therapy. Annual ultrasounds are part of our ongoing monitoring protocol.
Most side effects are manageable with the right approach:
For most people, yes — at least partially.
GLP-1 medications regulate hunger signals. They don't permanently reset your metabolism. When the medication stops, hunger cues often return.
This mirrors outcomes seen with both dietary interventions and bariatric surgery.
Sustainable results require sustainable habits: quality nutrition, adequate protein, strength training, hormonal balance, and gut health monitoring. The medication creates the conditions for change — lifestyle is what makes it last.
Emerging research points to a range of potential benefits, though it's not always clear whether these stem from weight loss itself or the medication's direct effects:
Before starting, ask yourself:
These aren't reasons to avoid treatment. They're the right questions to ask so you start with realistic expectations and a solid plan.
GLP-1 receptor agonists are among the most significant advances in metabolic medicine in decades. But they aren't a standalone solution.
Used with the right clinical oversight, nutrition strategy, and movement practices, they can be a powerful tool for reclaiming your health — not just losing weight.
If you're considering GLP-1 therapy, the best next step is a conversation with an experienced provider who understands the full picture.
Book a consultation with Indigo Health Clinic here
What is the difference betweensemaglutide and tirzepatide? Semaglutide targets theGLP-1 receptor only, while tirzepatide targets both GLP-1 and GIP receptors.Clinical trials show tirzepatide produces greater average weight loss, but both are effective. The right choice depends on your health history and how your body responds.
Will I gain the weight back if Is top taking GLP-1 medications? For most people, yes —at least partially. These medications regulate hunger signals but don't permanently reset metabolism. Sustained results require ongoing lifestyle changes including nutrition, strength training, and hormonal balance.
What are the most common side effects of GLP-1 medications? The most common side effects are gastrointestinal — nausea, bloating, constipation, and diarrhea. These typically improve with slow dose titration over 16 weeks. More serious but rare side effects include pancreatitis and gallbladder issues.
Are GLP-1 medications safe long-term? Current data is reassuring, but long-term safety research is still ongoing. At Indigo, we require thyroid and gallbladder ultrasounds before starting therapy and recommend annual monitoring throughout treatment.
Can GLP-1 medications help with conditions other than weight loss? Emerging research suggests benefits for cardiovascular health, metabolic markers, neuroprotection, and even reduction of cravings for alcohol and nicotine. Many of these benefits may be linked to weight loss itself, though some appear independent of it.
Questions? Reach us atdiscovery@indigohealthclinic.com or (202) 840-6622, Monday–Friday, 9AM–5PM EST.
March is here, and for most people, the momentum of January has already faded. If your health goals have quietly slipped away, you're not alone — and it's not about willpower. It's about strategy.
Still experiencing fatigue, brain fog, or inflammation after Lyme treatment? Discover why persistent Lyme symptoms often continue beyond infection, and how immune balance, nervous system regulation, and a systems-based approach can support long-term recovery.
Hours of Operation
Monday - Friday
9am - 5pm
